Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03043209 · ClinicalTrials.gov registry record
Genomic Sequencing in Patients With HCM Undergoing Septal Myectomy
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 25
- Enrollment target
NCT03043209 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 25 participants.
The verdict
NCT03043209 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Investigators aim to use comparative exome and/or genome sequencing to discover causative molecular lesions for phenotypes hypothesized to be caused by somatic mutations. For this study, investigators have targeted hypertrophic cardiomyopathy.
Interventions
- GENETIC Genomic sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-08-30 |
| Est. Completion | 2022-12-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03043209
The ClinicalTrials.gov registry entry for NCT03043209 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genomic sequencing is the first listed.
NCT03043209 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03043209 about?
NCT03043209 is a clinical study titled "Genomic Sequencing in Patients With HCM Undergoing Septal Myectomy". Investigators aim to use comparative exome and/or genome sequencing to discover causative molecular lesions for phenotypes hypothesized to be caused by somatic mutations. For this study, investigators have targeted hypertrophic cardiomyopathy.
What is the current status of trial NCT03043209?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2018-08-30. Estimated completion is 2022-12-28.
What interventions are being tested in trial NCT03043209?
The interventions under investigation include: Genomic sequencing (GENETIC).
Who is sponsoring clinical trial NCT03043209?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.